Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophrenia

被引:5
|
作者
Itahashi, Takashi [1 ]
Noda, Yoshihiro [2 ]
Iwata, Yusuke [3 ]
Tarumi, Ryosuke [2 ]
Tsugawa, Sakiko [2 ]
Plitman, Eric [5 ]
Honda, Shiori [2 ]
Caravaggio, Fernando [4 ,5 ]
Kim, Julia [4 ,5 ]
Matsushita, Karin [2 ]
Gerretsen, Philip [4 ,5 ]
Uchida, Hiroyuki [2 ,4 ]
Remington, Gary [4 ,5 ]
Mimura, Masaru [2 ]
Aoki, Yuta Y. [1 ]
Graff-Guerrero, Ariel [4 ,5 ]
Nakajima, Shinichiro [2 ,4 ]
机构
[1] Showa Univ, Med Inst Dev Disabil Res, Tokyo, Japan
[2] Keio Univ, Dept Neuropsychiat, Sch Med, Tokyo, Japan
[3] Univ Yamanashi, Dept Neuropsychiat, Fac Med, Kofu, Yamanashi, Japan
[4] Ctr Addict & Mental Hlth CAMH, Brain Hlth Imaging Ctr, Toronto, ON, Canada
[5] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
基金
日本学术振兴会; 加拿大健康研究院;
关键词
Classification; Cortical thickness; Schizophrenia; Treatment-resistant; INFERIOR FRONTAL GYRUS; GLUTAMATERGIC NEUROMETABOLITES; ANATOMICAL CONNECTIVITY; THICKNESS; DOPAMINE; DIAGNOSIS; CORTEX;
D O I
10.1016/j.nicl.2021.102852
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Background: One-third of patients with schizophrenia are treatment-resistant to non-clozapine antipsychotics (TRS), while the rest respond (NTRS). Examining whether TRS and NTRS represent different pathophysiologies is an important step toward precision medicine. Methods: Focusing on cortical thickness (CT), we analyzed international multi-site cross-sectional datasets of magnetic resonance imaging comprising 110 patients with schizophrenia (NTRS = 46, TRS = 64) and 52 healthy controls (HCs). We utilized a logistic regression with L1-norm regularization to find brain regions related to either NTRS or TRS. We conducted nested 10-fold cross-validation and computed the accuracy and area under the curve (AUC). Then, we applied the NTRS classifier to patients with TRS, and vice versa. Results: Patients with NTRS and TRS were classified from HCs with 65% and 78% accuracies and with the AUC of 0.69 and 0.85 (p = 0.014 and < 0.001, corrected), respectively. The left planum temporale (PT) and left anterior insula/inferior frontal gyrus (IFG) contributed to both NTRS and TRS classifiers. The left supramarginal gyrus only contributed to NTRS and right superior temporal sulcus and right lateral orbitofrontal cortex only to the TRS. The NTRS classifiers successfully distinguished those with TRS from HCs with the AUC of 0.78 (p < 0.001), while the TRS classifiers classified those with NTRS from HCs with the AUC of 0.69 (p = 0.015). Conclusion: Both NTRS and TRS could be distinguished from HCs on the basis of CT. The CT pathological basis of NTRS and TRS has commonalities, and TRS presents unique CT features.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Newer antipsychotics in treatment-resistant schizophrenia
    Marder, SR
    [J]. BIOLOGICAL PSYCHIATRY, 1999, 45 (04) : 383 - 384
  • [2] Atypical antipsychotics in treatment-resistant schizophrenia
    Schäfer, I
    Lambert, M
    Naber, D
    [J]. NERVENARZT, 2004, 75 (01): : 79 - 89
  • [3] Treatment-resistant schizophrenia: Clinical experience with new antipsychotics
    Bondolfi, G
    Baumann, P
    Dufour, H
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1996, 6 : 21 - 25
  • [4] Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
    Lally, John
    Gaughran, Fiona
    Timms, Philip
    Curran, Sarah R.
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2016, 9 : 117 - 129
  • [5] Role of newer atypical antipsychotics in the management of treatment-resistant schizophrenia
    Emsley, RA
    [J]. CNS DRUGS, 2000, 13 (06) : 409 - 420
  • [6] Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia
    Lindenmayer, JP
    Czobor, P
    Volavka, J
    Lieberman, JA
    Citrome, L
    Sheitman, B
    McEvoy, JP
    Cooper, TB
    Chakos, M
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (04) : 551 - 556
  • [7] Role of Newer Atypical Antipsychotics in the Management of Treatment-Resistant Schizophrenia
    Robin A. Emsley
    [J]. CNS Drugs, 2000, 13 : 409 - 420
  • [8] Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia
    de Bartolomeis, Andrea
    Ciccarelli, Mariateresa
    Vellucci, Licia
    Fornaro, Michele
    Iasevoli, Felice
    Barone, Annarita
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (18) : 2035 - 2052
  • [9] Defining treatment-resistant schizophrenia and response to antipsychotics: A review and recommendation
    Suzuki, Takefumi
    Remington, Gary
    Mulsant, Benoit H.
    Uchida, Hiroyuki
    Rajji, Tarek K.
    Graff-Guerrero, Ariel
    Mimura, Masaru
    Mamo, David C.
    [J]. PSYCHIATRY RESEARCH, 2012, 197 (1-2) : 1 - 6
  • [10] COMBINATION OF ECT AND DIBENZODIAZEPINE ANTIPSYCHOTICS IMPROVES TREATMENT RESPONSE IN TREATMENT-RESISTANT SCHIZOPHRENIA
    Oleneva, E. V.
    Mosolov, S. N.
    Tsukarzi, E. E.
    Alfimov, P. V.
    [J]. EUROPEAN PSYCHIATRY, 2014, 29